Experts discuss the role of nursing for setting expectations and managing irAEs in patients with melanoma receiving immunotherapy.
This activity is intended for nurses, nurse practitioners, and other healthcare professionals who treat patients with melanoma.
The goal of this activity is to review the challenges associated with using checkpoint inhibitors for melanoma from a nursing perspective, with a focus on the immune-related adverse events.
Approximate Time to Complete: 35 minutes
Course Available Beginninng: Nov. 2, 2019
Developed through a partnership between SITC and Medscape.
- Have increased knowledge regarding the clinical efficacy, unique response patterns, and safety profiles associated with cancer immunotherapies in patients with metastatic melanoma.
- Have greater competence related to developing strategies for the timely identification and mitigation of cancer immunotherapy associated adverse effects in patients with metastatic melanoma.